Acadian Asset Management LLC Penumbra Inc Transaction History

Acadian Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$238.08 - $288.0 $132,372 - $160,128	-556 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$250.72 - $291.24 $68,195 - $79,217	272 Added 95.77%	556 $147,000
Q2 2021 Aug 11, 2021	BUY	$235.0 - $310.7 $66,740 - $88,238	284 New	284 $78,000
Q1 2021 May 11, 2021	SELL	$175.6 - $291.43 $23,179 - $38,468	-132 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$174.98 - $272.83 $23,097 - $36,013	132 New	132 $23,000

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.09B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.